Nova (NASDAQ:NVMI – Get Free Report) issued an update on its fourth quarter 2026 earnings guidance on Thursday morning. The company provided earnings per share (EPS) guidance of 3.030-3.180 for the period, compared to the consensus EPS estimate of 3.020. The company issued revenue guidance of $305.0 million-$315.0 million, compared to the consensus revenue estimate of $306.1 million.
Nova Stock Performance
NASDAQ:NVMI opened at $280.30 on Friday. The stock has a fifty day moving average price of $347.53 and a two-hundred day moving average price of $437.96. The stock has a market capitalization of $8.91 billion, a price-to-earnings ratio of 34.69, a PEG ratio of 1.47 and a beta of 1.85. Nova has a 1 year low of $266.43 and a 1 year high of $615.99.
Nova (NASDAQ:NVMI – Get Free Report) last released its earnings results on Thursday, November 5th. The semiconductor company reported $2.86 EPS for the quarter, beating analysts’ consensus estimates of $2.77 by $0.09. The company had revenue of $287.84 million during the quarter, compared to the consensus estimate of $282.23 million. Nova had a return on equity of 21.41% and a net margin of 28.84%. Nova’s quarterly revenue was up 28.2% compared to the same quarter last year. During the same quarter last year, the company earned $2.16 earnings per share. Nova has set its Q4 2026 guidance at 3.030-3.180 EPS. On average, analysts predict that Nova will post 9.89 EPS for the current year.
Nova declared that its Board of Directors has authorized a share buyback program on Wednesday, September 2nd that allows the company to repurchase $200 million in shares. This buyback authorization allows the semiconductor company to reacquire up to 1.9% of its stock through open market purchases. Share buyback programs are usually an indication that the company’s management believes its stock is undervalued.
Wall Street Analysts Forecast Growth
Several research analysts recently weighed in on NVMI shares. Zacks Research downgraded shares of Nova from a “strong-buy” rating to a “hold” rating in a research note on Monday, October 5th. Citigroup downgraded shares of Nova from a “buy” rating to a “neutral” rating and lowered their price target for the stock from $550.00 to $415.00 in a report on Thursday, October 8th. Weiss Ratings reissued a “hold (c)” rating on shares of Nova in a research report on Friday, October 2nd. Jefferies Financial Group reissued a “buy” rating and set a $600.00 price objective on shares of Nova in a research note on Thursday, August 6th. Finally, Evercore set a $475.00 target price on shares of Nova in a research report on Friday, August 7th. Seven equities research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company’s stock. According to MarketBeat, Nova currently has a consensus rating of “Moderate Buy” and an average price target of $482.78.
Check Out Our Latest Analysis on Nova
Insider Transactions at Nova
In other Nova news, CEO Gabriel Waisman sold 1,500 shares of Nova stock in a transaction dated Tuesday, September 1st. The stock was sold at an average price of $342.27, for a total value of $513,405.00. Following the completion of the sale, the chief executive officer owned 27,214 shares in the company, valued at $9,314,535.78. The trade was a 5.22% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Shay Wolfing sold 3,864 shares of the stock in a transaction dated Monday, September 21st. The stock was sold at an average price of $363.28, for a total transaction of $1,403,713.92. Following the transaction, the insider owned 21,409 shares in the company, valued at approximately $7,777,461.52. The trade was a 15.29% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 1.00% of the stock is currently owned by company insiders.
More Nova News
Here are the key news stories impacting Nova this week:
- Positive Sentiment: Nova posted record Q3 revenue of $287.8 million, up 28% year over year, and adjusted EPS of $2.86, beating analyst estimates of $282.2 million and $2.77, respectively. Nova Reports Record Third Quarter 2026 Financial Results
- Positive Sentiment: Management’s earnings-call discussion highlighted strong growth and visibility into 2027, supporting the longer-term outlook. Nova Earnings Call Highlights Strong Growth and 2027 Visibility
- Neutral Sentiment: For Q4, Nova forecast revenue of $305 million–$315 million, around the $306.1 million consensus estimate, and EPS of $3.03–$3.18, slightly above the $3.02 consensus. The forecast is solid, but offers limited evidence of a substantial near-term beat. Nova Q4 Revenue and Growth Outlook
- Negative Sentiment: Needham lowered its price target to $420 from $570, while keeping a Buy rating. The cut may add pressure amid the stock’s decline, despite the results beat. Needham Analyst Recommendations
About Nova
Nova Ltd. (NASDAQ: NVMI) develops and supplies metrology and process-control solutions for the semiconductor manufacturing industry. Its systems help chipmakers measure and control critical dimensions, film thickness, material properties and other characteristics during the production of integrated circuits.
The company’s product portfolio includes optical and X-ray metrology systems, chemical metrology solutions, and related software and analytics tools. These technologies are used in multiple stages of semiconductor fabrication, including front-end wafer processing and advanced packaging, to support process development, yield improvement and manufacturing control.
Founded in 1993, Nova is headquartered in Rehovot, Israel, and serves semiconductor manufacturers and other industry customers through operations and support activities across North America, Europe and Asia.
Read More
- Five stocks we like better than Nova
- GE Aerospace Has a $170 Billion Backlog, But Is the Stock Worth the Premium?
- Google’s Credit Backstop May Be TeraWulf’s Biggest Advantage
- Could the Midterms Revive Medicare for All? 3 Healthcare Stocks to Watch
- Qualcomm Beat Earnings, But Its Fastest-Growing Businesses Have a Catch
Receive News & Ratings for Nova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nova and related companies with MarketBeat.com's FREE daily email newsletter.
